131 results on '"Dudani, Renu"'
Search Results
2. Production, purification and immunogenicity of Gag virus-like particles carrying SARS-CoV-2 components
3. Self-Amplifying RNA Generated with the Modified Nucleotides 5-MethylCytidine and 5-MethylUridine Mediate Strong Expression & Immunogenicity in vivo
4. Intranasal administration of unadjuvanted SARS‐CoV‐2 spike antigen boosts antigen‐specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters
5. Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters
6. Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern
7. Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant
8. A Method to Evaluate In Vivo CD8+ T Cell Cytotoxicity in a Murine Model
9. Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious
10. Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern
11. Blood-Based Immune Protein Markers of Disease Progression in Murine Models of Acute and Chronic Inflammatory Bowel Disease
12. Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology
13. Effect of Chiral Purity on Adjuvanticity of Archaeol-Based Glycolipids
14. Intranasal Immunization with a Proteosome-Adjuvanted SARS-CoV2 Spike Protein-Based Vaccine is Immunogenic and Efficacious in Mice & Hamsters
15. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium
16. Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model
17. The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model
18. Pre‐clinical development of a blood‐brain barrier (BBB)‐penetrating anti‐amyloid‒β fusion protein
19. Assessment of stability of sulphated lactosyl archaeol archaeosomes for use as a vaccine adjuvant
20. Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins
21. Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma
22. Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization
23. Assessment of stability of sulphated lactosyl archaeol archaeosomes for use as a vaccine adjuvant.
24. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations
25. Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice
26. DYNAMICS OF THE NUCLEUS DURING LYMPHOCYTE ACTIVATION
27. An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma
28. Pathogen Proliferation Governs the Magnitude but Compromises the Function of CD8 T Cells1
29. IFN-gamma induces the erosion of preexisting CD8 T cell memory during infection with a heterologous intracellular bacterium
30. Delayed expansion and contraction of CD8+T cell response during infection with virulent Salmonella typhimurium.: J.Immunol
31. Prolonged antigen-presentation, antigen presenting cell- and CD8+ T cell turnover during mycobacterial infection: comparison with Listeria monocytogenes.': J.Immunol
32. Mycobacterium bovis BCG-infected mice are more susceptible to Staphylococcal Enterotoxin B-mediated toxic shock than uninfected Mice despite reduced in vitro splenocyte responses to the superantigens
33. Pre-existing inflammation due to Mycobacterium bovis (BCG) infection differentially modulates T cell priming against a replicating or a non-replicating immunogen.: Infect.Immun
34. Multiple mechanisms compensate to enhance tumor-protective CD8+ T cell response in the long-term despite poor CD8+ T cell priming initially: Comparison between an acute versus a chronic intracellular bacteirum expressing a model antigen.: J.Immunol
35. Cross-reactive antigen is required to prevent erosion of established T cell memory and tumor immunity: A heterologous bacterial model of attrition.: J.Immunol
36. Intrinsic Role of FoxO3a in the Development of CD8+ T Cell Memory
37. Modulation of Antigenic Location Converts Chronic into Acute Infection by Forcing CD8+ T Cell Recognition
38. CD8+ T Cells Primed in the Periphery Provide Time-Bound Immune-Surveillance to the Central Nervous System
39. IFN-γ Expressed by T Cells Regulates the Persistence of Antigen Presentation by Limiting the Survival of Dendritic Cells
40. IFN-γ Induces the Erosion of Preexisting CD8 T Cell Memory during Infection with a Heterologous Intracellular Bacterium
41. Pathogen Proliferation Governs the Magnitude but Compromises the Function of CD8 T Cells
42. Mutation in the Fas Pathway Impairs CD8+ T Cell Memory
43. Delayed Expansion and Contraction of CD8+ T Cell Response during Infection with Virulent Salmonella typhimurium
44. Reducing the Stimulation of CD8+ T Cells during Infection with Intracellular Bacteria Promotes Differentiation Primarily into a Central (CD62LhighCD44high) Subset
45. Prolonged Antigen Presentation, APC-, and CD8+ T Cell Turnover during Mycobacterial Infection: Comparison with Listeria monocytogenes
46. Cross-Reactive Antigen Is Required to Prevent Erosion of Established T Cell Memory and Tumor Immunity: A Heterologous Bacterial Model of Attrition
47. Mycobacterium bovis BCG-Infected Mice Are More Susceptible to Staphylococcal Enterotoxin B-Mediated Toxic Shock than Uninfected Mice despite Reduced In Vitro Splenocyte Responses to Superantigens
48. Multiple Mechanisms Compensate to Enhance Tumor-Protective CD8+ T Cell Response in the Long-Term Despite Poor CD8+ T Cell Priming Initially: Comparison Between an Acute Versus a Chronic Intracellular Bacterium Expressing a Model Antigen
49. Preexisting Inflammation Due toMycobacterium bovisBCG Infection Differentially Modulates T-Cell Priming against a Replicating or Nonreplicating Immunogen
50. Modulation of Antigenic Location Converts Chronic into Acute Infection by Forcing CD8+ T Cell Recognition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.